Scarica l'app Stockscreener
10.27
12.67%
-1.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand - Yahoo Finance
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - Zacks Investment Research
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market - Yahoo Finance
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $11 at TD Cowen - StreetInsider
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 144 Ginkgo Bioworks Holdings For: 12 October By Investing.com - Investing.com South Africa
DNA Surges As Ginkgo Bioworks Lands Key AI Drug Deals - Timothy Sykes
What's Going on With Ginkgo Bioworks Stock on Friday? - Benzinga
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program - www.marketscreener.com
Ginkgo Bioworks Provides Autonomous Lab Access To National Science Foundation X-Labs Researchers, Contributing Cloud Lab Time And Protein Testing Services To $1.5 Billion Breakthrough Science Program - www.marketscreener.com
Researchers in a $1.5 billion science initiative will be able to use a robot lab remotely. - Stock Titan
Ginkgo Bioworks, Araceli Biosciences Add Cellular Imaging to Autonomous Lab - www.marketscreener.com
Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop - Financial Times
Ginkgo Bioworks CFO Steven Coen sells $36,045 in stock - Investing.com
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know - Zacks Investment Research
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Ginkgo Bioworks CFO Steven Coen Sells 2,403 Shares Under Rule 10b5-1 Plan on October 5, 2026 - Kalkine Media
A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan
Ginkgo Bioworks: The Valuation Has Outrun The Business (NYSE:DNA) - Seeking Alpha
Officer Steven P. Coen proposes selling 2,403 Ginkgo Bioworks (NYSE: DNA) shares. - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Ginkgo Bioworks: Another Curious Rally (NYSE:DNA) - Seeking Alpha
AbbVie and Takeda can use AI models without revealing sequences to other members - Stock Titan
Ginkgo Bioworks (DNA) Slips 1.88% to $10.46, Testing the Middle of a Well-Defined RangeWide Range Bar - siam.in
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
AI-Driven Innovation Reshapes Vaccine Adjuvant Discovery as Investment Surges Across Public and Private Sectors - GlobeNewswire Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - finance.yahoo.com
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains? - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges in the Biotech Sector - DirectorsTalk Interviews
Ginkgo Bioworks (DNA) officer may sell 2,200 shares - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Ginkgo Bioworks (NYSE: DNA) director sells 5,000 shares near $7.08 - Stock Titan
Ginkgo Bioworks And Eli Lilly And Company Enter Partnership To Integrate Ginkgo Datapoints With Lilly TuneLab - marketscreener.com
Director plans potential 5,000-share sale at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Up to $17.5M awarded to Ginkgo for medicines made for one patient - Stock Titan
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines - Investing News Network
BTIG cuts Ginkgo Bioworks stock price target on transition concerns By Investing.com - Investing.com Australia
DNAGinkgo Bioworks Holdings Inc Earnings - Finviz
BTIG cuts Ginkgo Bioworks stock price target on transition concerns By Investing.com - Investing.com South Africa
BTIG cuts Ginkgo Bioworks stock price target on transition concerns By Investing.com - Investing.com Canada
BTIG cuts Ginkgo Bioworks stock price target on transition concerns - Investing.com
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $5 at BTIG - StreetInsider
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $5 - Moomoo
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target By Investing.com - Investing.com Canada
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target By Investing.com - Investing.com India
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target By Investing.com - Investing.com Nigeria
BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target - investing.com
5.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):